Piper Jaffray analyst Matthew O’Brien reiterated a Buy rating on Motus Gi Holdings Inc (NASDAQ: MOTS) on August 14 and set a price target of $8. The company’s shares opened today at $5.35.
According to TipRanks.com, O’Brien is a top 100 analyst with an average return of 26.5% and a 69.8% success rate. O’Brien covers the Healthcare sector, focusing on stocks such as Boston Scientific Corp, Zimmer Biomet Holdings, and Merit Medical Systems.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Motus Gi Holdings Inc with a $10 average price target, an 86.9% upside from current levels. In a report released yesterday, Oppenheimer also maintained a Buy rating on the stock with a $10 price target.
.
See today’s analyst top recommended stocks >>
The company has a one-year high of $10.66 and a one-year low of $3.75. Currently, Motus Gi Holdings Inc has an average volume of 118.4K.
Based on the recent corporate insider activity of 23 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of MOTS in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
